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REVIEW
Abstract— Background: The use of Negative Pressure Wound
Dressing has been found to promote the wound healing process,
therefore, reducing the risk of surgical site complications. The
use of this technique amongst breast cancer patients, who have
often encountered a distressing journey, may prove beneficial in
making the post-operative process less eventful. Many of these
patients have a limited time window to start adjuvant treatment.
The use of a negative pressure device is recommended in both
prophylactic and therapeutic scenarios. NPWT may also be used
in patients who have undergone cosmetic breast surgery. We
have evaluated the use of NPWT in breast surgery with an
updated and systematic review of the available literature.
Methods: The authors systematically searched the PubMed,
Science Direct, and Wiley Online databases using the phrases
“Negative Pressure Wound Therapy in Breast surgery” and
“Vacuum-Assisted Closure in Breast Wound” and all publi-
cations, including relevant data were considered eligible for
inclusion in the review.
Results: We have found reports of 7 studies, 3 retrospective,
2 prospective, one randomized trial, and one case series. The
complication rate in the NPWT group versus conventional
dressing group has been reported in 5 papers. A statistically
significant effect in favor of NPWT was documented in three
trials.
Conclusion: The current evidence supports the notion that
NPWT systems are beneficial in enhancing the healing of
complicated breast wounds. However, larger studies exploring
the effectiveness of this technique would be of interest to breast
surgeons.
Keywords—Negative Pressure Wound Therapy, vacuum-
assisted closure, Breast cancer, Breast reconstruction
Introduction
THE scope of breast surgery includes the managementof benign and malignant breast disease either by mas-
tectomy with or without reconstruction (autologous tissue
as well as implant-based) or breast conservative surgery.
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Furthermore, it also encompasses aesthetic surgery such as
breast augmentation or reduction. Complications associated
with the post-operative wound-healing process remain one of
the most common challenges and are potentially associated
with delaying adjuvant therapy and diminishing the aesthetic
result.
The benefits of using the Negative Pressure Wound Dress-
ing in Breast surgery have been well documented.
Breast cancer is considered the most frequently detected
female malignancy worldwide and the dominant cause of
cancer-related mortality amongst women.1 Although breast
surgery is typically associated with a low risk of surgical
site infection (SSI), the use of the Negative Pressure Wound
Dressing further results in a favorable outcome.
We have studied available data that discuss the effective-
ness of negative pressure wound therapy (NPWT) systems
in the management of post-surgical wounds involving the
breast.
Methods
The PRISMA principles have been followed during this
review preparation. The PubMed, Science Direct, Wiley
Online databases, and Scopus databases have been searched
systematically. All the papers that revealed relevant data were
considered eligible for inclusion in the review.
Inclusion criteria
We have looked at studies involving patients that un-
derwent surgical breast procedures. The intervention under
exploration was the use of NPWT in postoperative wounds.
The comparator treatment was conventional dressings in-
cluding dry wound dressing, alginate dressings or saline-
soaked gauze dressings. Original papers such as randomized
controlled trials (RCTs), retrospective studies, prospective
studies, and case series have been included and the full
text of the paper was explored. Papers that do not refer
to the use of NPWT in breast surgery were excluded. The
primary outcome was complete wound closure. No minimum
patient sample size per trial was required and no restriction
was placed for study dates or periods. After selection, seven
original research papers met the inclusion criteria and were
finally included in this review,(one randomized trial, three
cohort retrospective studies, two prospective studies, and one
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Figure 1. Mechanism of action in negative pressure wound therapy. Modified
from Bruke et al. 2014
case series). The studies involved 492 female patients treated
with NPWT versus 584 patients treated with conventional
dressing methods.
Results
A. Mechanism of action
The use of Negative Pressure Wound Dressing promotes
wound healing by triggering several healing pathways i.e.
angiogenesis which improves tissue oxygenation and aids
migrating the inflammatory cells to the healing site. It also
aids the diversion of the wound exudate away from the wound
and promotes patient independence and improves quality of
life.2–4
B. Device types and indications
The current devices that provide NPWT are vacuum-
assisted closure (VAC) system and PICOTM dressing. The
PICOTM dressing is a canister free; single-use topical NPWT
system that maintains –80 mmHg pressure (Fig. 2). The
NPWT systems are used to manage complex wounds such as
those which are infected, diabetic foot ulcers, post-traumatic
wounds, burns, and necrotizing fasciitis.5
NPWT concept is continually evolving. In addition to the
use of conventional NPWT it may also be used to man-
age post-surgical wound complications or as a prophylactic
measure to reduce the infection risk.6 Negative Pressure
Wound Therapy with the installation system (NPWTi) has
also been developed. It incorporates the traditional NPWT
and a local irrigation system within the wound cavity. NPWTi
significantly reduces the growth of biofilm that colonize the
wound cavity. Such formation of biofilm is considered to
be one of the main factors impairing the wound healing
process.7
Stoeckel et al. retrospectively analyzed the data of 18
patients who had post-operative breast wound complications
treated with NPWT. 15 of the patients underwent surgery
for breast cancer, two had reduction mammoplasty, and one
Figure 2. PICOTM dressing in breast surgery
was treated for a recurrent primary breast abscess. 12 of
the 15 cancer patients underwent mastectomy had subse-
quent breast reconstruction procedures. Seven wounds were
related to implant or tissue expander placement. Four patients
had complicated transverse rectus abdominus myocutaneous
(TRAM) flap wounds, and one had a latissimus dorsi flap
wound. 15 of 18 patients were treated effectively using
NPWT. Two patients required muscle flap coverage. The
hospital stay ranged from 3 to 54 days with a mean of
12.1 days. NPWT dressing has been used to promote wound
healing after skin grafting, or as a mean to prepare the
wound for surgical closure. Seven of the wounds healed
by secondary intention, six were successfully treated with
subsequent skin grafting, and two were treated with delayed
primary closure. Two wounds were both complicated by
tissue ischemia and infection requiring operative debridement
(Tab. I). The authors concluded that vacuum-assisted closure
therapy promotes faster healing and stimulates the formation
of healthy granulation tissue.8
C. NPWT in oncoplastic breast surgery boosts incision clo-
sure
Holt and Murphy from South Manchester University Hos-
pital conducted a study to assess if the application of negative
pressure wound therapy dressings (PICOTM) on closed inci-
sions in patients undergoing therapeutic resection promotes
superior wound healing. 24 consecutive patients (over 20
months) were included in the study. They either underwent
a therapeutic mammoplasty or skin-sparing mastectomy and
immediate reconstruction with inferior dermal flap and im-
plant placement. All patients had a simultaneous symmet-
ric breast reduction at the same sitting. The therapeutic
procedure side was supplied with PICOTM dressings while
the opposite breast reduction was dressed with conventional
dressings. The overall rate of wound dehiscence was 4.2%
(n = 1) on the therapeutic procedure side compared with
16.7% (n = 4) on the contralateral breast reduction side.
The mean time to complete healing was 10.7 days in the
therapeutic side treated with PICOTM compared with 16.1
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days on the contralateral side. One mastectomy patient had
delayed wound healing at the T-junction on both sides (Tab.
I). The authors concluded that this evidence further supports
the use of NPWT in oncoplastic breast procedures, as it
reduces the rates of wound dehiscence, boosts healing, and
allows commencement of adjuvant therapy.9
Ferrando et al. conducted a prospective study that included
37 cases. ciNPT was used in 17 cases (46%), whereas the
remaining 20 (54%) had conventional post-operative wound
dressing. The difference in complication rate between the 2
groups was significant, the ciNPT sample showed complica-
tion rates of only 1/25 (4%), as compared to 45% (10 out of
22) in the standard care group (Tab. I). The study outcome
supports the use of ciNPT in oncological breast surgery.
Furthermore, the dressing is well-tolerated, adaptable, and
has shown to improve scar outcomes especially in patients
presenting with high-risk factors.10
Gabriel et al. investigated closed incision Negative Pres-
sure Therapy (ciNPT) with a customizable dressing on 13 pa-
tients (25 breasts) who received immediate postmastectomy
reconstruction as part of 2-stage expander/implant breast
reconstruction. Nipple-sparing mastectomy was performed
on 14 breasts, reduction-pattern mastectomy on 6 breasts, and
skin-sparing mastectomy on 5 breasts. All post-mastectomy
incisions were managed with ciNPT. The single-use therapy
unit provided continuous negative pressure (–125 mmHg)
with a replaceable 45 ml exudate canister. The wound dress-
ing and ciNPT unit were designed for placement for up to 7
days. Surgical drains were routed under the skin beyond the
ciNPT dressing and they functioned independently of ciNPT
. The majority of patients (56.0%) were treated with nipple-
sparing mastectomy. Overall mean ciNPT duration ranged
from 3 to 5 days. The mean drain placement was 8.2 days.
After three months follow-up, 96% (24/25 breasts) achieved
complete healing. Superficial dehiscence occurred in 12%
(3/25 breasts), and flap necrosis occurred in 4% (1/25 breasts)
in the breast reduction-pattern group. One patient from
the nipple-sparing mastectomy group developed a delayed
hematoma postoperatively. No superficial wound dehiscence
required surgical intervention. One obese, diabetic patient
developed a flap necrosis which required surgical revision.
All other breasts healed and remained closed at 3-month
follow-up (Tab. I). The paper concluded that ciNPT could be
a viable option for wounds after immediate post-mastectomy
reconstruction.11
In a cohort of 206 patients (228 breasts), Kim et al. exam-
ined the usefulness of the ciNPT to reduce mastectomy flap
necrosis in immediate expander-based breast reconstruction.
The incisional-NPWT group (45 breasts) had a lower overall
complication rate in comparison with a conventional dressing
group (11.1% vs. 27.9%, p = 0.019). In detail, the overall
mastectomy flap necrosis rate was 8.9 % (versus 23.5 %; p =
0.030), and major mastectomy flap necrosis rate was 2.2 %
(versus 13.7 %; p = 0.031 compared with the conventional
dressing group, Tab. I). The paper concluded that the use of
NPWT is an effective method in reducing mastectomy flap
necrosis in expander-based breast reconstruction.12
Gabriel et al. conducted a retrospective study comparing
postoperative outcomes in patients who were treated with
ciNPT versus standard of care (SOC) after breast reconstruc-
tion following mastectomy procedures. The authors investi-
gated the medical records of 356 patients (ciNPT = 177,
SOC = 179) with 665 closed breast incisions (ciNPT = 331,
SOC = 334). Overall complication rate was 8.5% (28/331) in
ciNPT group compared with 15.9% (53/334) in SOC group
(p = 0.0092). Compared with the SOC group, the ciNPT
group had significantly lower infection rates (7/331 (2.1%)
versus 15/334 (4.5%), respectively; p = 0.0225). Time to
complete drain removal per breast for ciNPT versus SOC
groups was 9.9 versus 13.1 days (p < 0.0001), respectively.
Patients who received ciNPT over closed incisions following
mastectomy and breast reconstruction experienced a shorter
time to surgical drain removal and significantly lower rates of
infection, dehiscence, necrosis, and seromas, compared with
the SOC group.13
D. NPWT in breast surgery transplants
Angspatt et al. in 2017 evaluated the efficacy of NPWT
in preventing donor site seroma formation after the harvest
of a latissimus dorsi muscle flap for breast reconstruction.
It was a prospective matched-pair study, 40 patients were
included. 20 patients had NPWT dressing at the donor site,
and conventional wound dressing was used in the control
group (n = 20). In the NPWT group, seroma incidence after
the drain removal was significantly lower than in the control
group (15% vs. 70%; odds ratio = 0.07, relative risk, 0.24).
Both the mean percutaneous aspirated volume (p = 0.004)
and the frequency of percutaneous aspirations (p = 0.001)
were also significantly lower in the NPWT group (Tab. I).
The paper concluded that the use of NPWT reduces the
seroma incidence after drain removal from the latissimus
dorsi flap harvesting site.14
E. ciNPT after reduction mammoplasty decreases wound
dehiscence risk
Galiano et al. presented a multinational, prospective, ran-
domized, open trial to evaluate the efficacy of PICOTM
(canister free; single-use NPWT system) on the prevention of
post-surgical incision healing complications in 200 patients
undergoing bilateral reduction mammoplasty (Tab. I). One
patient arm was treated with PICOTM on one breast and Steri-
strips on the contralateral side. This group was assessed for
local wound complications three weeks after the operation.
Secondary objectives were to assess post-surgical complica-
tions (such as skin necrosis, hematoma, wound dehiscence
and seromas), scar quality and the ease of application of
PICOTM versus standard wound care. The outcome revealed
a trend towards fewer complications and adverse events in
the PICOTM group compared to conventional wound care.
Results also found a 38% decrease in wound dehiscence,
which was statistically significant.15
F. Complex cases
NPWT can also be used to manage complex postoperative
complications relating to breast implant placement such as
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Table I
NPWT in Breast Oncoplastic Surgery
Author Age
range
Patient
number,
Breast
number
Complications
rates in NPWT
vs. Conventional
methods
Mean
NPWT
duration
(days)
Outcome
Stoeckel et al. 2006
Retrospective study Mean 52
T:18, (18)
C: 0, (0) no data 15 Fifteen of the 18 patients weredefinitively treated with the VAC
Holt et al. 2015
case series 42–70
T: 24, (24)
C: 24, (24)
1/24 (4.2%) vs.
4/24 (16.7%) 6 The study further supports the useof negative pressure wound therapy
on incised wounds
Gabriel et al. 2016
retrospective cohort study 27–62
T: 13, (26)
C: 0, (0)
5/26 (19%) vs.
no data 4.3 By 3-month follow-up 24 of 25(96%) breasts achieved healing.
Kim et al. 2016
prospective cohort study 34–49
T :44, (45)
C: 162, (183)
5/45 (11.1%) vs.
51/183 (27.9%) 3 The use of NPWT in patientswho underwent breast reconstruc-
tion significantly reduced the inci-
dence rates of overall wound re-
lated complications.
Galiano et al. 2018
international, RCT 18–65
T: 199, (199)
C: 199, (199)
113 (56.8%) vs.
123 (61.8%) 14 NPWT group had fewer healingcomplications than the conven-
tional dressing group
Gabriel et al. 2018
retrospective cohort study 40–64
T: 177, (331)
C: 179, (334)
28 (8.5%) vs.
53 (15.9%) 9 Patients who received ciNPT overclosed incisions experienced sig-
nificantly lower rates of wound
complications, compared with the
SOC group
Ferrando et al. 2018
prospective cohort study no data
T: 17, (25)
C: 20, (22)
1/25 (4%) vs.
10/22 (45%) 7 The results support the use ofciNPT in oncological breast
surgery
* ciNPT; Closed Incision Negative Pressure Therapy, SOC: Standard Care of Therapy The complications included superficial
dehiscence, skin flap necrosis infection, seroma, haematoma and exposed implant, T: Patients treated with NPWT methods,
Breasts number, C: Patients treated with conventional methods, Breasts number, RCT - randomized control trial
implant exposure after Acellular Dermal Matrix (ADM)
reconstruction or following Nipple Area Complex (NAC) —
sparing mastectomy. The NPWT allows for a rapid implant
replacement after the implant pocket infection has been re-
solved.16, 17 Risk factors promoting surgical site infections in-
clude high BMI, diabetes mellitus, hypoalbuminemia, smok-
ing, status post-chemotherapy, COPD, anemia, and immune-
compromised patients. NPWT provides a safe alternative in
such populations.
G. Surgical Site Infection and NPWT
It has been reported that NPWT, when applied prophy-
lactically to a closed surgical wound, results in a decrease
in the incidence of wound complications such as infection
or collection of fluid.15 Strugala et al., in 2017, conducted
a meta-analysis to determine the impact of prophylactic use
of NPWT on SSI, wound dehiscence and length of hospital
stay. The outcome revealed a significant reduction of SSI
from 12.5% to 5.2% with NPWT use. Wound dehiscence
rate was reduced from 17.4% to 12.8% with NPWT, and
the mean reduction in hospital length of stay (in patients
treated with NPWT) was also significant (–0.47 days). Such
observations also encourage the use of NPWT in a wide range
of abdominal, orthopedic and colorectal procedures.18
Post-operative wound-related complications following
breast surgery varies from 7 to 31% in the literature.19, 20
Consequences include a prolonged hospital stay, delay in ad-
juvant treatment delivery, poor cosmesis, the need for further
surgery and increased management costs. Furthermore, the
use of negative pressure wound dressing and its associated
benefits in reducing complications plays a part in easing a
patient’s psychological stress in the post-operative period.
Conclusion
One in eight women is affected by breast cancer during
their lifetime and surgery is an essential element in the
management pathway.21 As the majority of breast cancer
patients will require adjuvant treatment after surgery, swift
recovery is essential in preventing delays. Such delays ulti-
mately affect outcome and survival. Furthermore, NPWT may
play a role in improving the cosmetic outcome by reducing
the tension in the surgical wound, obliteration of the dead
space and minimizing tissue injury by protecting the wound
from contamination and infection.22 Randomized controlled
clinical trials that are currently under progress will show if
the NPWT is able to provide women underging immediate
breast reconstruction, better outcomes due to a faster healing
process and superior aesthetic results when compared to the
conventional post-operative wound dressings.23
The current evidence supports the notion that NPWT
systems are beneficial in enhancing the healing of compli-
cated breast wounds. However, larger studies exploring the
effectiveness of this technique are required.
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